Biography:Louise Showe
Louise C. Showe is an American biomedical researcher who was scientific director of the Genomics Facility and the Bioinformatics Facility at The Wistar Institute in Philadelphia.[1][2][3] Her research focused on functional genomics and how they can be used to better understand the immune system and cancer. She retired in 2024.[4]
Showe has said that being able to "globally screen gene expression patterns using genomics and proteomics appears to have injected a new level of enthusiasm for learning what is going on in complex cancers that have been particularly recalcitrant to therapy."[5] Recently, Showe's research led to the creation of a blood test that could be used to test for lung cancer using a 29-gene assay.[6] The company OncoCyte has partnered with Wistar to develop lung cancer diagnostic tests.[7]
References
- ↑ "Louise C. Showe, Ph.D.". The Wistar Institute. http://www.wistar.org/our-science/scientists/louise-c-showe-phd. Retrieved 18 February 2014.
- ↑ "Louise C. Showe". The University of Pennsylvania. http://www.med.upenn.edu/apps/faculty/index.php/g5455356/p1988563. Retrieved 18 February 2014.
- ↑ "Wistar establishes research center for advanced biology studies". Philadelphia Business Journal. http://www.bizjournals.com/philadelphia/stories/2008/05/19/newscolumn2.html. Retrieved 18 February 2014.
- ↑ "Dr. Louise Showe Reflects on 40 Years at Wistar". Wistar Institute. January 26, 2024. https://www.wistar.org/featured-news/dr-louise-showe-reflects-on-40-years-at-wistar/. Retrieved January 4, 2025.
- ↑ "Benefiting from the Human Genome". The Scientist. http://www.the-scientist.com/?articles.view/articleNo/13354/title/Benefiting-from-the-Human-Genome/. Retrieved 18 February 2014.
- ↑ "Health: Local Researchers Developing Lung Cancer Blood Test". CBS Philly. http://philadelphia.cbslocal.com/2011/12/21/health-local-researchers-developing-lung-cancer-blood-test/. Retrieved 18 February 2014.
- ↑ "BioTime's Subsidiary OncoCyte Corporation and The Wistar Institute To Collaboratively Develop Cancer Diagnostics". BioTime Inc.. http://phx.corporate-ir.net/phoenix.zhtml?c=83805&p=irol-newsArticle&ID=1864514&highlight=. Retrieved 18 February 2014.
External links
